About eMolecules
eMolecules is a company based in San Diego (United States) founded in 2005. The company has 100 employees as of December 31, 2022. eMolecules has completed 2 acquisitions, including Specs Compound Handling and Synple Chem. eMolecules offers products and services including Chemical Search Platform, Compound Reformatting, Building Blocks, Screening Compounds, and Custom Chemistry. eMolecules operates in a competitive market with competitors including ProQuest, ResearchGate, Authorea, Research Solutions and Mendeley, among others.
- Headquarter San Diego, United States
- Employees 100 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
100
as on Dec 31, 2022
-
Investments & Acquisitions
Specs Compound Handling
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of eMolecules
eMolecules offers a comprehensive portfolio of products and services, including Chemical Search Platform, Compound Reformatting, Building Blocks, Screening Compounds, and Custom Chemistry.
Platform for searching and ordering chemical compounds from suppliers.
Service for reformatting chemicals into required formats.
Catalog of chemical building blocks for research purposes.
Collection of compounds for drug screening applications.
Tailored chemistry services for specific research needs.
People of eMolecules
Unlock access to complete
Funding Insights of eMolecules
Investors in eMolecules
eMolecules has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Avista Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are focused on the United States market.
|
Locked | Locked | Locked |
Investor details for eMolecules
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by eMolecules
eMolecules has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Specs Compound Handling and Synple Chem.
Investment portfolio details for eMolecules
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Automated chemical synthesizers are developed using reagent capsules.
|
Locked | Locked | 2016 | Locked | |
|
Contract research and compound management services are provided globally.
|
Locked | Locked | 1987 | Locked |
Complete acquisition details for eMolecules
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - eMolecules
Detailed financials for eMolecules
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emolecules Comparisons
Peer comparison for eMolecules
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of eMolecules
eMolecules operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProQuest, ResearchGate, Authorea, Research Solutions and Mendeley, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Research content is delivered via online platforms to libraries.
|
|
| Locked | Locked | Locked |
Online community for scientists
|
|
| Locked | Locked | Locked |
Collaborative platform for research and learning
|
|
| Locked | Locked | Locked |
AI-powered solutions for scholarly content access and management are provided.
|
|
| Locked | Locked | Locked |
Research management and collaboration are enabled via a web/mobile platform.
|
Detailed competitors of eMolecules
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emolecules
Complete news archive for eMolecules
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about eMolecules
eMolecules was founded in 2005 and raised its 1st funding round 16 years after it was founded.
eMolecules is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
As of Dec 31, 2022, the latest employee count at eMolecules is 100.
eMolecules was founded in 2005 in San Diego, United States. An online platform is operated by the company within the biotechnology sector, focusing on drug discovery. Services include a search engine that accesses uncharted chemical and biological compounds. Users are enabled to explore and source these materials for research purposes. The domain emolecules.com is utilized for operations, serving global pharmaceutical and research needs.
eMolecules's top competitors include ProQuest, ResearchGate and Research Solutions.
eMolecules offers Chemical Search Platform, Compound Reformatting, Building Blocks, Screening Compounds, and Custom Chemistry.
eMolecules has made 2 acquisitions, including Specs Compound Handling, and Synple Chem.
eMolecules has 1 investor. Key investors include Avista Capital Partners.